Holly Ung is a member of the Interventional Immunology in Early Life Diseases Research group in the The Ritchie Centre.
Areas of interest
What is your research about and what do you hope to achieve?
Interleukin 37 is a potent anti-inflammatory cytokine and part of the interleukin 1 family which governs principal pathways during inflammation but also homeostasis. With my PhD, I contribute to research investigating mechanism of regulation and action of interleukin 37. For example, how IL-37 imparts a strong inhibition on the production of pro-inflammatory cytokines and protects against a wide spectrum of inflammatory assaults.
What opportunities have you had at Hudson Institute?
The collaborative and supportive work environment of Hudson Institute has given me extensive opportunities to learn from and work with brilliant researchers both at the Institute and the Monash Biomedicine Discovery Institute, as well as internationally during an internship with Fraunhofer Institute for Cell Therapy and Immunology in Germany.
How will your research help others?
With my PhD I hope to contribute to a better understanding of the mechanisms by which anti-inflammatory cytokines suppress inflammation and harness their therapeutic potential for clinical use in the future.